Importantly, due to mtDNA heteroplasmy and the potential cell type and tissue specificity of mitochondrial phenotypes, it is critical for future studies to consider the source of the sample, preparation, and technical and methodological differences of assays to resolve the variation in findings in LRRK2 PD and mitochondrial diseases [132]. The gene discussed is LRRK2; the disease is Parkinson disease.